Community Bank N.A. Has $1.46 Million Stock Position in CVS Health Corporation $CVS

Community Bank N.A. decreased its stake in CVS Health Corporation (NYSE:CVS) by 23.2% in the second quarter, HoldingsChannel reports. The firm owned 21,233 shares of the pharmacy operator’s stock after selling 6,398 shares during the period. Community Bank N.A.’s holdings in CVS Health were worth $1,464,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Bell Investment Advisors Inc boosted its position in shares of CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares during the period. Roxbury Financial LLC boosted its position in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the period. ORG Partners LLC lifted its stake in CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares in the last quarter. Saudi Central Bank purchased a new stake in CVS Health in the 1st quarter worth about $34,000. Finally, Livelsberger Financial Advisory purchased a new stake in CVS Health in the 2nd quarter worth about $35,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Up 0.8%

CVS opened at $78.50 on Tuesday. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $79.68. The business has a 50-day moving average of $72.63 and a 200-day moving average of $67.75. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The company has a market capitalization of $99.56 billion, a PE ratio of 21.93, a price-to-earnings-growth ratio of 0.86 and a beta of 0.60.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. During the same period last year, the business earned $1.83 EPS. The business’s quarterly revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 74.30%.

Insider Buying and Selling at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.22% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CVS shares. Wall Street Zen raised CVS Health from a “hold” rating to a “buy” rating in a research note on Sunday, September 21st. Wolfe Research increased their price objective on CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Barclays increased their price objective on CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Cowen reissued a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Finally, UBS Group raised CVS Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $67.00 to $79.00 in a research note on Monday, August 18th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $79.80.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.